Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2011
Stomach cancer and myositis ossificans-like lesions
Judith Maresch, Martha Hoffmann, Markus Raderer, et al.
Clinical Nuclear Medicine
|
September 28, 2002
Imaging of cutaneous recurrence of gastric cancer with F-18 FDG positron emission tomography
Martha Hoffmann, Georg Oberhuber, Kurt Kletter, et al.
Leukemia & Lymphoma
|
October 21, 2005
Transformation of MALT lymphoma to pure plasma cell histology following treatment with the anti-CD20 antibody rituximab
Stefan Woehrer, Berthold Streubel, Andreas Chott, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 21, 2014
The role of SPECT/CT in radioembolization of liver tumours
Hojjat Ahmadzadehfar, Heying Duan, Alexander R Haug, et al.
Annals of Hematology
|
April 3, 2004
18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) does not visualize follicular lymphoma of the duodenum
Martha Hoffmann, Andreas Chott, Andreas Püspök, et al.
Thyroid : Official Journal of the American Thyroid Association
|
March 10, 2010
Rituximab plus dose-reduced cyclophosphamide, mitoxantrone, vincristine, and prednisolone are effective in elderly patients with diffuse large B-cell lymphoma of the thyroid
Constanze Jonak, Marlene Troch, Leonhard Müllauer, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
|
October 1, 2008
SPECT/CT fusion imaging in radionuclide cisternography for localization of liquor leakage sites
Clemens Novotny, Christian Pötzi, Susanne Asenbaum, et al.
Oncology
|
May 22, 2003
18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma
Martha Hoffmann, Kurt Kletter, Alexander Becherer, et al.
Haematologica
|
February 3, 2004
Positron emission tomography with [18F] 2-fluoro-D-2- deoxyglucose in primary cutaneous T-cell lymphomas
Julia Valencak, Alexander Becherer, Manon Der-Petrossian, et al.
Haematologica
|
April 14, 2011
Bortezomib combined with rituximab and dexamethasone is an active regimen for patients with relapsed and chemotherapy-refractory mantle cell lymphoma
Wolfgang Lamm, Hannes Kaufmann, Markus Raderer, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2011
Stomach cancer and myositis ossificans-like lesions
Judith Maresch, Martha Hoffmann, Markus Raderer, et al.
Clinical Nuclear Medicine
|
September 28, 2002
Imaging of cutaneous recurrence of gastric cancer with F-18 FDG positron emission tomography
Martha Hoffmann, Georg Oberhuber, Kurt Kletter, et al.
Leukemia & Lymphoma
|
October 21, 2005
Transformation of MALT lymphoma to pure plasma cell histology following treatment with the anti-CD20 antibody rituximab
Stefan Woehrer, Berthold Streubel, Andreas Chott, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 21, 2014
The role of SPECT/CT in radioembolization of liver tumours
Hojjat Ahmadzadehfar, Heying Duan, Alexander R Haug, et al.
Annals of Hematology
|
April 3, 2004
18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) does not visualize follicular lymphoma of the duodenum
Martha Hoffmann, Andreas Chott, Andreas Püspök, et al.
Thyroid : Official Journal of the American Thyroid Association
|
March 10, 2010
Rituximab plus dose-reduced cyclophosphamide, mitoxantrone, vincristine, and prednisolone are effective in elderly patients with diffuse large B-cell lymphoma of the thyroid
Constanze Jonak, Marlene Troch, Leonhard Müllauer, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
|
October 1, 2008
SPECT/CT fusion imaging in radionuclide cisternography for localization of liquor leakage sites
Clemens Novotny, Christian Pötzi, Susanne Asenbaum, et al.
Oncology
|
May 22, 2003
18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma
Martha Hoffmann, Kurt Kletter, Alexander Becherer, et al.
Haematologica
|
February 3, 2004
Positron emission tomography with [18F] 2-fluoro-D-2- deoxyglucose in primary cutaneous T-cell lymphomas
Julia Valencak, Alexander Becherer, Manon Der-Petrossian, et al.
Haematologica
|
April 14, 2011
Bortezomib combined with rituximab and dexamethasone is an active regimen for patients with relapsed and chemotherapy-refractory mantle cell lymphoma
Wolfgang Lamm, Hannes Kaufmann, Markus Raderer, et al.
Page
of 4